Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 37 min ago
Peer-reviewedCC BYMedicine

Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis

  • Mohammed Alfawaz1
  • Dareen Bajamaan2
  • Lama Alghamdi2
  • Yara Alorfi3
  • Saud Khared2
  • Nada Ameen2
  • Rahaf Alamri2
  • Mohammed Abuladel2
  • Rayan Alshehri2
  • Shaima Altowairqi2
  1. 1Department of Internal Medicine, Gastroenterology Consultant, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia
  2. 2Medical Intern, College of Medicine, University of Jeddah, Jeddah, Saudi Arabia
  3. 3Internal Medicine Resident, Department of Internal Medicine, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia.
Read full textPDFCite

Related

  1. Successive and Isoform-Specific Remodeling of Hepatic Drug-Metabolizing Enzymes during Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis Progression
    Yusuke Ando, Takumi Arai, Yuki Tsukui +4
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textPharmacology & toxicologyJ-STAGE
  2. GLP-1 receptor agonists in metabolic dysfunction-associated steatohepatitis: protocol for a systematic review and meta-analysis of randomized controlled trials
    Shi-ping Sun, Yan Fang, Li Liu +2
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Prediction Models Versus Fibrosis-4 Index (FIB-4) for Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Verification-Audited Systematic Review and Meta-Analysis
    Syed Muhammad Hassan Bukhari, Ushna Shahid, Wahhaj Qayyum +3
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation Recurrence After Catheter Ablation: A Systematic Review and Meta-Analysis
    Panagiotis Theofilis, Paschalis Karakasis, Panayotis K. Vlachakis +7
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Effectiveness of eHealth lifestyle interventions on management of metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.
    Yangguo Zhao, Xinrui Yang, Yang Bai +2
    Nutrition & diabetesPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCDOAJ

Cite

BibTeXRIS
BibTeX
@article{alfawaz2026efficacy,
  title = {{Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis}},
  author = {Mohammed Alfawaz and Dareen Bajamaan and Lama Alghamdi and Yara Alorfi and Saud Khared and Nada Ameen and Rahaf Alamri and Mohammed Abuladel and Rayan Alshehri and Shaima Altowairqi},
  journal = {Medicine},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13706190},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
AU  - Mohammed Alfawaz
AU  - Dareen Bajamaan
AU  - Lama Alghamdi
AU  - Yara Alorfi
AU  - Saud Khared
AU  - Nada Ameen
AU  - Rahaf Alamri
AU  - Mohammed Abuladel
AU  - Rayan Alshehri
AU  - Shaima Altowairqi
PY  - 2026
DA  - 2026/10/23
JO  - Medicine
UR  - https://europepmc.org/article/PMC/PMC13706190
SN  - 0304-5412
SN  - 1536-5964
ER  -